Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia

Author： Tzeng Tsang-Bin   Schneck Dennis W.   Birmingham Bruce K.   Mitchell Patrick D.   Zhang Harry   Martin Paul D.   Kung Li-Pin  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.9, 2008-09, pp. : 2575-2585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment study

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1268-1279

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetics of edoxaban and its main metabolite in a dedicated renal impairment study

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1268-1279

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Model‐Based Prediction of Pharmacokinetics in the Renal Impairment Population

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 364-376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Garenoxacin pharmacokinetics in subjects with renal impairment

By Krishna Gopal   Gajjar Diptee   Swan Suzanne   Marbury Thomas   Grasela Dennis M.   Wang Zaiqi  

Current Medical Research and Opinion, Vol. 23, Iss. 3, 2007-03 ,pp. : 649-657

Informa Healthcare

Access to resources Recommend Favorite

Effect of renal impairment on the pharmacokinetics of antimony in hamsters

By Zaghloul I.Y.   Al-Jasser M.  

Annals of Tropical Medicine and Parasitology, Vol. 98, Iss. 8, 2004-12 ,pp. : 793-800

Maney Publishing

Access to resources Recommend Favorite